These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38428778)

  • 1. A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy.
    Elasbali AM; Al-Soud WA; Anwar S; Alhassan HH; Adnan M; Hassan MI
    Int J Biol Macromol; 2024 Apr; 264(Pt 1):130544. PubMed ID: 38428778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B; Wood MJA; Roberts TC
    RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.
    Sardone V; Ellis M; Torelli S; Feng L; Chambers D; Eastwood D; Sewry C; Phadke R; Morgan JE; Muntoni F
    PLoS One; 2018; 13(3):e0194540. PubMed ID: 29579078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.
    Pichavant C; Aartsma-Rus A; Clemens PR; Davies KE; Dickson G; Takeda S; Wilton SD; Wolff JA; Wooddell CI; Xiao X; Tremblay JP
    Mol Ther; 2011 May; 19(5):830-40. PubMed ID: 21468001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of Duchenne muscular dystrophy and new therapeutic strategies].
    Podkalicka P; Myszka M; Dulak J; Łoboda A
    Postepy Biochem; 2022 Jun; 68(2):109-122. PubMed ID: 35792643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR Therapeutics for Duchenne Muscular Dystrophy.
    Erkut E; Yokota T
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DMD gene and therapeutic approaches to restore dystrophin.
    Fortunato F; Farnè M; Ferlini A
    Neuromuscul Disord; 2021 Oct; 31(10):1013-1020. PubMed ID: 34736624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duchenne muscular dystrophy.
    Duan D; Goemans N; Takeda S; Mercuri E; Aartsma-Rus A
    Nat Rev Dis Primers; 2021 Feb; 7(1):13. PubMed ID: 33602943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
    Sun C; Shen L; Zhang Z; Xie X
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32717791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.
    Wilson K; Faelan C; Patterson-Kane JC; Rudmann DG; Moore SA; Frank D; Charleston J; Tinsley J; Young GD; Milici AJ
    Toxicol Pathol; 2017 Oct; 45(7):961-976. PubMed ID: 28974147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting fibrosis in Duchenne muscular dystrophy.
    Zhou L; Lu H
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):771-6. PubMed ID: 20613637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.
    Starosta A; Konieczny P
    Cell Mol Life Sci; 2021 Jun; 78(11):4867-4891. PubMed ID: 33825942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.
    Koo T; Wood MJ
    Hum Gene Ther; 2013 May; 24(5):479-88. PubMed ID: 23521559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.